These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 6263521

  • 21. Amiodarone phenocopy of Fabry's keratopathy.
    Whitley CB, Tsai MY, Heger JJ, Prystowsky EN, Zipes DP.
    JAMA; ; 249(16):2177-8. PubMed ID: 6300478
    [No Abstract] [Full Text] [Related]

  • 22. Electron microscopic observations on cultured fibroblasts from Fabry heterozygotes and hemizygotes.
    Wandall A, Hasholt L, Sørensen SA.
    Ultrastruct Pathol; 1982; 3(1):51-8. PubMed ID: 6280349
    [Abstract] [Full Text] [Related]

  • 23. Glycosidases of Ehrlich ascites tumor cells and ascitic fluid--purification and substrate specificity of alpha-N-acetylgalactosaminidase and alpha-galactosidase: comparison with coffee bean alpha-galactosidase.
    Yagi F, Eckhardt AE, Goldstein IJ.
    Arch Biochem Biophys; 1990 Jul; 280(1):61-7. PubMed ID: 2162155
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Purification and partial characterization of human liver alpha-galactosidase: is alpha-galactosidase B an alpha-N-acetylgalactosaminidase?
    Dean KJ, Sung SS, Sweeley CC.
    Adv Exp Med Biol; 1978 Jul; 101():515-23. PubMed ID: 208364
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW, Hamers MN, Oldenbroek-Haverkamp E, Strijland A, de Jonge A, van den Bergh FA, Tager JM.
    Biochim Biophys Acta; 1978 Dec 08; 527(2):456-64. PubMed ID: 31916
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls.
    Kobayashi T, Shinnoh N, Kuroiwa Y.
    J Neurol Sci; 1984 Aug 08; 65(2):169-77. PubMed ID: 6090593
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.
    Peltier A, Herbeuval E, Brondeau MT, Belleville F, Nabet P.
    Biomedicine; 1977 May 08; 26(3):194-201. PubMed ID: 407951
    [Abstract] [Full Text] [Related]

  • 38. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
    Yuasa T, Fukuma M, Takashima S, Takaki R.
    Arch Pathol Lab Med; 1980 Jun 08; 104(6):321-7. PubMed ID: 6246846
    [Abstract] [Full Text] [Related]

  • 39. Studies on human liver alpha-galactosidases. III. Partial characterization of carbohydrate-binding specificities.
    Dean KJ, Sweeley CC.
    J Biol Chem; 1979 Oct 25; 254(20):10006-10. PubMed ID: 226533
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.